Lydia Finley, PhD, one of the speakers planned for the symposium Effect of Metabolic Stress on Insulin Action on Sunday morning, June 14, talks about her background and previews her presentation, “Metabolic Regulation of Cell Fate Decisions,” which begins at 9:20 a.m. CT Sunday, June 14.
Cecilia C. Low Wang, MD, FACP, previews her presentation “Management of Steroid-Associated Hyperglycemia in Inpatient and Outpatient Settings,” which begins at 11:40 a.m. CT Saturday, June 13.
Korey Hood, PhD, previews his presentation “Is One Size Fits All Actually A Bad Approach?” which beings at 4:30 p.m. CT Saturday, June 13.
Bruce Verchere, PhD, previews his presentation “Pro-Islet Amyloid Polypeptide Processing in Diabetes,” which begins at 2:45 p.m. CT Saturday, June 13.
Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, previews the Professional Interest Group Discussion “Diabetes Self-Management Education and Support (DSMES)—Focus on 2020 DSMES Consensus Report,” which begins at 12:00 p.m. CT Sunday, June 14.
Session Chair Matthew Hirschey, PhD, interviews Isha Jain, PhD, the first of three speakers planned for Effect of Metabolic Stress on Insulin Action on Sunday morning, June 14. Dr. Jain’s presentation, “Role of Hypoxia in Mediating Metabolic Improvements,” begins at 8:00 a.m. CT.
Sarah Hallberg, DO, MS, ACSM-CEP, FOMA, FNLA, previews her presentation “Dietary Fat as a Cause of Metabolic Disease,” which begins at 11:30 a.m. CT Friday, June 12.
Elias Spanakis, MD, previews his presentation “Use of Continuous Glucose Monitoring Devices in the Hospital—Time for Glucose Telemetry?” which begins at 12:05 p.m. CT Saturday, June 13.
Edward C. Chao, DO, previews the Professional Interest Group Discussion “Clinical Centers and Programs — Frequently Encountered Glycemic Management Issues without Clear Guidelines,” for which he is the chair. The session begins at 11:30 p.m. CT Saturday, June 13.
The International Hypoglycemia Study Group recently proposed a revised classification of hypoglycemia that has been adopted by the ADA, the European Association for the Study of Diabetes, and a number of other organizations. Simon R. Heller, MD, FRCP, discusses the rationale behind the IHSG’s proposed definitions, how these definitions have impacted current guidelines, and what…